Quantum BioPharma Ltd. (QNTM)
6.23
-0.49 (-7.29%)
At close: Apr 15, 2025, 3:57 PM
6.03
-3.21%
After-hours: Apr 15, 2025, 06:07 PM EDT
-7.29% (1D)
| Bid | 6.37 |
| Market Cap | 14.33M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -13.12 |
| PE Ratio (ttm) | -0.47 |
| Forward PE | -0.38 |
| Analyst | n/a |
| Ask | 6.93 |
| Volume | 102,695 |
| Avg. Volume (20D) | 2,821,219 |
| Open | 6.52 |
| Previous Close | 6.72 |
| Day's Range | 6.06 - 6.80 |
| 52-Week Range | 2.70 - 35.10 |
| Beta | 0.69 |
About QNTM
Quantum BioPharma Ltd., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity tha...
Sector Healthcare
IPO Date n/a
Employees NaN
Stock Exchange NASDAQ
Ticker Symbol QNTM
Website https://www.quantumbiopharma.com
3 weeks ago
+18.6%
Quantum Biopharma shares are trading higher after ...
Unlock content with
Pro Subscription
1 month ago
+3.41%
Quantum Biopharma shares are trading higher after the company announced it completed its trial titled "A Phase 1, Randomised, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of Lucid-21-302 in Healthy Adult Participants."
